Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Primary Biliary Cholangitis - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides ...

DelveInsight’s Primary Biliary Cholangitis Market Insights report includes a comprehensive understanding of current treatment practices, primary biliary cholangitis emerging drugs, market share of ...

Large PBC cohort shows current liver stiffness measurement >10 kPa predicts hepatic decompensation, outperforming biochemical response or LSM trajectory. Learn more ...

Results from the GLISTEN study, the largest investigational trial of pruritus in primary biliary cholangitis (PBC), indicate ...

Seladelpar is an oral, selective peroxisome proliferator-activated receptor delta agonist. Treatment with seladelpar was associated with an improvement in cholestatis markers in patients with primary ...

—A recent study provides genetic evidence linking a higher body mass index (BMI) to an increased risk of primary biliary cholangitis and autoimmune hepatitis but a decreased risk of primary sclerosing ...

Distinct lipid changes in primary biliary cholangitis may signal inflammation and fibrosis. Discover how these findings could ...

The cholangitis infection is often caused by bacteria, a gallstone or any another blockage. Primary biliary cholangitis is a chronic condition where inflammation of the bile duct system keeps bile ...

Please provide your email address to receive an email when new articles are posted on . International Primary Biliary Cholangitis Day, celebrated on September 10, aspires to raise awareness of the ...

Seladelpar, an investigational selective agonist of peroxisome proliferator–activated receptor-delta (PPAR-δ), significantly improves liver biomarkers of disease activity and bothersome symptoms of ...

AMSTERDAM — Patients with an incomplete response to first-line therapy for primary biliary cholangitis are significantly more likely to achieve a complete biochemical response with bezafibrate ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In this video, Nancy S. Reau, MD, FAASLD, AGAF, highlights a presentation at the ACG Annual ...